Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Net operating loss (NOL) carryforwards by Year
Net operating loss (NOL) carryforwards — U.S. federal ($M) ($M)
Vertex Pharmaceuticals Net operating loss (NOL) carryforwards: $57.3M in FY2025, down 62.4% from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-13) ↗
Reported in Form 10-K Note (Income Taxes).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net operating loss (NOL) carryforwards — U.S. federal ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 57.3 | -62.4% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 152 | +186.8% | Form 10-K (filed 2025-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 53.1 | -18.7% | Form 10-K (filed 2024-02-15) ↗ |
| FY2022 | Dec 31, 2022 | 65.3 | +119.1% | Form 10-K (filed 2023-02-10) ↗ |
| FY2021 | Dec 31, 2021 | 29.8 | -69.4% | Form 10-K (filed 2022-02-09) ↗ |
| FY2020 | Dec 31, 2020 | 97.4 | -93.5% | Form 10-K (filed 2021-02-11) ↗ |
| FY2019 | Dec 31, 2019 | 1,500 | – | Form 10-K (filed 2020-02-13) ↗ |
Breakdown
What makes up net operating loss (NOL) carryforwards
Cite this data
StockData. (2026). Vertex Pharmaceuticals Net operating loss (NOL) carryforwards ($M), annual FY2019–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/nol-dom
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.